4148
全宇生技-KY
-0.65 (-1.94%)32.9046成交張數12.16本益比0.81股價淨值比2.98%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入
營業收入20252,949年增 +19.9%
毛利率202528.1%最新一期
營業利益率202510.1%最新一期
每股盈餘20252.28年增 +13.4%
| 會計項目 | 走勢 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 銷貨收入淨額 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 營業收入合計 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 銷貨成本 | 66.8% | – | – | 77.3% | 73.0% | 69.3% | 79.2% | 72.8% | 71.9% | |
| 營業成本合計 | 66.8% | 71.2% | 77.8% | 77.3% | 73.0% | 69.3% | 79.2% | 72.8% | 71.9% | |
| 營業毛利（毛損） | 33.2% | 28.8% | 22.2% | 22.7% | 27.0% | 30.7% | 20.8% | 27.2% | 28.1% | |
| 營業毛利（毛損）淨額 | 33.2% | 28.8% | 22.2% | 22.7% | 27.0% | 30.7% | 20.8% | 27.2% | 28.1% | |
| 推銷費用 | 6.9% | 7.4% | 6.2% | 7.4% | 9.1% | 6.7% | 5.7% | 9.5% | 7.9% | |
| 管理費用 | 8.1% | 7.0% | 8.9% | 9.3% | 8.1% | 6.2% | 8.4% | 10.9% | 9.8% | |
| 研究發展費用 | 0.2% | 0.2% | 0.3% | 0.2% | 0.2% | 0.1% | 0.1% | 0.2% | 0.1% | |
| 預期信用減損損失（利益） | – | 1.0% | 2.7% | -0.5% | -2.8% | -0.2% | -0.1% | 0.3% | 0.2% | |
| 營業費用合計 | 15.2% | 15.5% | 18.1% | 16.4% | 14.6% | 12.7% | 14.1% | 20.9% | 18.1% | |
| 營業利益（損失） | 18.0% | 13.3% | 4.1% | 6.3% | 12.4% | 18.0% | 6.7% | 6.3% | 10.1% | |
| 利息收入 | – | – | – | 1.1% | 0.4% | 0.3% | 1.1% | 1.4% | 0.8% | |
| 其他收入 | 0.6% | 0.8% | 1.9% | 0.7% | 0.6% | 0.5% | 0.2% | 0.6% | 0.2% | |
| 其他利益及損失淨額 | -0.0% | 1.5% | 0.3% | 1.3% | 1.3% | -1.2% | 1.1% | 2.0% | -0.6% | |
| 財務成本淨額 | 0.6% | 0.7% | 0.5% | 0.3% | 0.2% | 0.5% | 0.1% | 0.2% | 0.5% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | -0.0% | -0.0% | -0.1% | 0.1% | 0.1% | 0.2% | 0.1% | 0.2% | |
| 營業外收入及支出合計 | 0.0% | 1.6% | 1.7% | 2.9% | 2.2% | -0.9% | 2.4% | 3.9% | 0.0% | |
| 稅前淨利（淨損） | 18.0% | 14.8% | 5.9% | 9.1% | 14.6% | 17.1% | 9.1% | 10.3% | 10.1% | |
| 所得稅費用（利益）合計 | 0.5% | 1.9% | 3.7% | 3.1% | 3.9% | 4.8% | 2.4% | 3.2% | 3.1% | |
| 繼續營業單位本期淨利（淨損） | 17.5% | 13.0% | 2.2% | 6.0% | 10.8% | 12.3% | 6.7% | 7.1% | 7.0% | |
| 本期淨利（淨損） | 17.5% | 13.0% | 2.2% | 6.0% | 10.8% | 12.3% | 6.7% | 7.1% | 7.0% | |
| 確定福利計畫之再衡量數 | – | – | – | – | – | – | -0.0% | 0.0% | -0.0% | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | – | – | – | – | – | 0.0% | -0.0% | |
| 不重分類至損益之其他項目 | 3.0% | -0.0% | -0.7% | -5.4% | -7.1% | 3.6% | -4.0% | 10.9% | 6.4% | |
| 與不重分類之項目相關之所得稅 | – | – | – | – | – | – | -0.0% | 0.0% | -0.0% | |
| 不重分類至損益之項目： | – | – | -0.7% | -5.4% | -7.1% | 3.6% | -4.0% | 10.9% | 6.3% | |
| 國外營運機構財務報表換算之兌換差額 | -0.0% | -0.1% | 0.1% | -0.2% | 0.1% | -0.2% | 0.2% | -1.0% | -1.6% | |
| 與可能重分類之項目相關之所得稅 | -0.0% | -0.0% | 0.0% | -0.0% | 0.0% | -0.0% | 0.0% | -0.2% | -0.0% | |
| 後續可能重分類至損益之項目： | – | – | 0.1% | -0.1% | 0.1% | -0.1% | 0.1% | -0.8% | -1.6% | |
| 其他綜合損益（淨額） | 3.0% | -0.1% | -0.6% | -5.6% | -7.1% | 3.4% | -3.9% | 10.1% | 4.8% | |
| 本期綜合損益總額 | 20.5% | 12.9% | 1.6% | 0.4% | 3.7% | 15.8% | 2.8% | 17.2% | 11.8% | |
| 母公司業主（淨利∕損） | 14.3% | 11.4% | 2.0% | 5.0% | 9.0% | 9.9% | 4.9% | 5.2% | 5.2% | |
| 非控制權益（淨利∕損） | 3.2% | 1.6% | 0.2% | 1.0% | 1.8% | 2.4% | 1.8% | 1.9% | 1.8% | |
| 母公司業主（綜合損益） | 16.9% | 11.3% | 1.6% | 0.3% | 3.1% | 12.8% | 1.7% | 13.2% | 8.8% | |
| 非控制權益（綜合損益） | 3.6% | 1.6% | 0.1% | 0.1% | 0.6% | 2.9% | 1.1% | 4.0% | 2.9% | |
| 基本每股盈餘 | 0.2% | 0.2% | 0.0% | 0.1% | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | |
| 繼續營業單位淨利（淨損） | 0.0% | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 稀釋每股盈餘 | 0.2% | 0.2% | 0.0% | 0.1% | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。